A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Potential Effects of Ranitidine on the Pharmacokinetics of Lesinurad in Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2014
Price : $35 *
At a glance
- Drugs Lesinurad (Primary) ; Ranitidine
- Indications Duodenal ulcer; Gastric ulcer; Gout; Peptic ulcer
- Focus Pharmacokinetics
- Sponsors Ardea Biosciences
- 08 Jan 2014 Status changed from active, no longer recruiting to completed.
- 03 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Aug 2013 New trial record